» Articles » PMID: 12684387

Molecular Therapeutics: is One Promiscuous Drug Against Multiple Targets Better Than Combinations of Molecule-specific Drugs?

Overview
Journal Clin Cancer Res
Specialty Oncology
Date 2003 Apr 10
PMID 12684387
Citations 2
Authors
Affiliations
Soon will be listed here.
Citing Articles

Pazopanib: a novel multitargeted tyrosine kinase inhibitor.

Sonpavde G, Hutson T Curr Oncol Rep. 2007; 9(2):115-9.

PMID: 17288876 DOI: 10.1007/s11912-007-0007-2.


Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors.

Barnett S, Defeo-Jones D, Fu S, Hancock P, Haskell K, Jones R Biochem J. 2004; 385(Pt 2):399-408.

PMID: 15456405 PMC: 1134710. DOI: 10.1042/BJ20041140.